Valuation: Celltrion, Inc.

Market Cap 44,385B 33.45B 29.86B 27.55B 25.03B 46.95B 3,169B 47.67B 332B 131B 1,660B 126B 123B 5,259B P/E 2026 *
29x
P/E 2027 * 25.3x
Enterprise Value 46.02B 34.69M 30.96M 28.56M 25.95M 48.68M 3.29B 49.43M 344M 136M 1.72B 130M 127M 5.45B EV / Sales 2026 *
8.23x
EV / Sales 2027 * 7.17x
Free-Float
58.02%
Yield 2026 *
0.37%
Yield 2027 * 0.4%
1 day-1.67%
1 week+6.70%
Current month+9.34%
1 month+8.85%
3 months+14.23%
6 months+0.01%
Current year+12.72%
1 week 189,500
Extreme 189500
203,500
1 month 173,700
Extreme 173700
203,500
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 123,408.34
Extreme 123408.337691
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%+6.70%+14.42%+56.67% 34B
-4.10%-8.54%+40.05%+66.99% 66.22B
-0.41%+3.27%+10.46%+72.82% 55.2B
+0.74%+4.04%+12.18%+88.71% 52.79B
+0.61%+2.69%+27.75%+50.97% 45.53B
-1.08%+2.19%+21.92%+131.38% 43.94B
-3.39%-0.83%+254.27%+571.04% 41.64B
-0.53%-6.60%+26.82%-2.45% 25.84B
+1.30%+4.94%+38.23%+28.59% 23.51B
-1.77%-0.59%-15.59%-1.36% 22.93B
Average -1.03%+0.95%+43.05%+106.34% 41.16B
Weighted average by Cap. -1.21%+0.79%+44.73%+115.44%

Financials

2026 *2027 *
Net sales 5,598B 4.22B 3.77B 3.47B 3.16B 5.92B 400B 6.01B 41.85B 16.49B 209B 15.83B 15.5B 663B 6,367B 4.8B 4.28B 3.95B 3.59B 6.73B 455B 6.84B 47.6B 18.75B 238B 18.01B 17.63B 754B
Net income 1,531B 1.15B 1.03B 950M 863M 1.62B 109B 1.64B 11.45B 4.51B 57.27B 4.33B 4.24B 181B 1,774B 1.34B 1.19B 1.1B 1B 1.88B 127B 1.91B 13.26B 5.22B 66.34B 5.02B 4.91B 210B
Net Debt 1,639B 1.24B 1.1B 1.02B 924M 1.73B 117B 1.76B 12.26B 4.83B 61.32B 4.64B 4.54B 194B 1,273B 959M 856M 790M 718M 1.35B 90.87B 1.37B 9.52B 3.75B 47.61B 3.6B 3.52B 151B
Projected Income Statement - Annual - Celltrion, Inc.
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-10-22 ₩194,300.00 -1.67% 520,793
26-10-21 ₩197,600.00 +0.10% 601,867
26-10-20 ₩197,400.00 -0.40% 705,641
26-10-19 ₩198,200.00 +2.16% 701,654
26-10-16 ₩194,000.00 +6.53% 1,112,319
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Celltrion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
194,300.00KRW
Average target price
267,840.44KRW
Spread / Average Target
+37.85%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Celltrion, Inc.
  1. Stock Market
  2. Stocks
  3. A068270 Stock